SBTXSkinbiotherapeuticsSBTX info
$0.13info-0.94%24h
Global rank
Market cap$21.67M
Change 7d-14.95%
YTD Performance-30.98%
SP500 benchmarkUnderperform
P/E-7.65
P/S131.28
Revenue$165.04K
Earnings-$3.54M
Dividend yield-
Main Sector
Healthcare

Skinbiotherapeutics SBTX Operating Margins

Operating Margin in 2022: -22.44%

According to Skinbiotherapeutics latest financial reports the company has an operating margin of -22.44%, an decrease of -38.19% to 2022. At the end of 2022 company had an operating margin of -36.32%.

Skinbiotherapeutics Operating Margin from 2022 to 2024

-
Value:-

SBTX Operating Margin History by year

YearOperating MarginChange
2023-22.44%-38.19%
2022-36.32%-

View the highest operating margin companies arrow right

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org